In a regulatory filing, Colgate-Palmolive (CL) chairman, president, and CEO Noel Wallace disclosed the sale of 45,568 common shares of the company on February 4 at a price of $93.9145 per share, or a total consideration of $4.28M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target raised to $88 from $83 at Barclays
- Colgate-Palmolive price target raised to $96 from $86 at TD Cowen
- Colgate-Palmolive price target raised to $97 from $93 at JPMorgan
- Colgate-Palmolive price target raised to $100 from $90 at BofA
- Colgate-Palmolive price target raised to $105 from $95 at Citi